期刊文献+

大肠癌组织中ABCG2的表达及临床病理意义 被引量:1

The correlation between the expressions of ABCG2 and clinicopathological parameters of colorectal cancer
原文传递
导出
摘要 目的通过检测大肠癌组织中ABCG2在蛋白和mRNA水平的表达量,分析该基因及蛋白的表达与大肠癌临床病理的关系。方法分别采用SYBR Green实时定量RT-PCR技术及免疫组化SP法检测35例大肠癌患者的癌组织及相应癌旁和远端正常组织中ABCG2基因的mRNA及蛋白的表达;评价其基因及蛋白的表达与临床病理参数的关系。结果大肠癌组织中ABCG2蛋白的阳性表达率显著高于正常组织(P<0.05);ABCG2 mRNA在癌组织中的表达显著高于癌旁及正常组织(P<0.05);ABCG2的表达高低与肿瘤直径有关(χ2=5.55,P=0.018);肿瘤低分化患者ABCG2 mR-NA阳性表达率明显高于肿瘤中-高分化患者;ABCG2的表达与患者性别、年龄、淋巴结转移、Duke分期及组织浸润深度无明显关系。结论大肠癌ABCG2的表达水平与患者肿瘤发生、发展及分化程度密切相关,检测其表达水平不但可以预测大肠癌患者预后而且对指导制订化疗方案有一定参考价值。 Objective To investigate the expressions of ABCG2 in colorectal cancer and its correlation with clinical pathologies.Methods The expressions of ABCG2 mRNA in 35 cases of colorectal cancer,adjacent and distal non-cancerous tissues were quantified by SYBR Green real-time RT-PCR.The expression of ABCG2 protein and relationship with clinical parameters and the differential expression of genes were detected by immunohistochemistry(SP method).Results The protein positive rate of ABCG2 in colorectal cancer was significantly higher than that in normal tissue.There were statistically significant differences among cancer tissues,adjacent and distal non-cancerous tissues,and normal tissues for positive expression of ABCG2 mRNA(P<0.05).There was significant corelationship between the expression of ABCG2 and tumor diameter(χ2=5.55,P=0.018).The mRNA expressions of ABCG2 in patients with poor differentiated tumors were much higher than those patients with well differentiated tumors.No corelationship was found between the mRNA expression of ABCG2 and sex,age,lymph node metastasis,Duke staging and depth of invasion.Conclusions The expression of ABCG2 in colorectal cancer is closely related with the developing and differentiated of the tumors.To detect the levels of the ABCG2 expression not only can predict the patients' prognosis but also has reference value to guide the development of chemotherapy.
出处 《中华临床医师杂志(电子版)》 CAS 2011年第12期3436-3440,共5页 Chinese Journal of Clinicians(Electronic Edition)
基金 广东省自然科学基金(9151008004000014)
关键词 肠肿瘤 载体蛋白质类 基因表达 病理学 临床 Intestinal neoplasms Carrier proteins Gene expression Pathology,clinical
  • 相关文献

参考文献10

  • 1王英泽,段相林,李永福,梁兴杰.半分子转运蛋白ABCG2的肿瘤多药耐药性研究及其应用[J].生物化学与生物物理进展,2009,36(12):1523-1529. 被引量:7
  • 2袁庶强,周志伟,梁永钜,符立梧,陈功,邱海波,张丽仪.三维培养药敏实验测定的结直肠癌化疗敏感性与多药耐药基因蛋白表达的关系[J].癌症,2009,28(9):932-938. 被引量:8
  • 3吴芳,张弘纲.预测大肠癌化疗疗效的分子或基因指标[J].癌症进展,2006,4(3):248-254. 被引量:2
  • 4Daniele C,Barbara P,Alwssio N,et al.A gene-wide investigation on polymorphisms in the ABCG2/BCRPtransporter and susceptibility to colorectal cancer. Mutation Research . 2008
  • 5Gupta N,Martin PM,Miyauchi S,et al.Down-regulation of BCRP/ABCG2in colorectal and cervical cancer. Biochemical and Biophysical Research Communications . 2006
  • 6Jemal A,Siegel R,Ward E,et al.Cancer statistics, 2007. CA A Cancer Journal for Clinicians . 2007
  • 7Diestra JE,Scheffer GL,Catala I,et al.Frequent expression of the multi-drug resistance-associated protein BCRP/MXR/ABCP/ABCG2 in human tumours detected by the BXP-21 monoclonal antibody in paraffin-embedded material. Journal of Paleopathology . 2002
  • 8Yoh K,Ishii G,Yokose T,et al.Breast cancer resistance protein impacts clinical outcome in platinum-based chemotherapy for advanced non-small cell lung cancer. Clinical Cancer Research . 2004
  • 9Doyle LA,Ross DD.Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2). Oncegene . 2003
  • 10Wang J,Guo LP,Chen LZ,et al.Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line. Cancer Research . 2007

二级参考文献100

  • 1徐建明,朱步东,Mangia Anita,Simone Gianni,Montemurro Severino,Giuliani Francesco,Maiello Evaristo,Colucci Giuseppe,Paradiso Angelo.胸苷酸合成酶和拓扑异构酶-1及Ki-67对伊立替康联合5-氟脲嘧啶治疗晚期大肠癌的预测价值[J].中华肿瘤杂志,2005,27(5):312-315. 被引量:9
  • 2桂贤,刘惠敏,何金,李玉莉,孙静,余宏宇.MRP、LRP在人大肠癌组织中的表达及临床意义[J].肿瘤防治研究,2005,32(8):499-501. 被引量:7
  • 3吴芳,张弘纲.预测大肠癌化疗疗效的分子或基因指标[J].癌症进展,2006,4(3):248-254. 被引量:2
  • 4Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007 [J]. CA Cancer J Clin, 2007, 57(1):43-66.
  • 5Technology Evaluation Center Assessment Program. Chemotherapy sensitivity and resistance assays [J]. Tecnologica MAP Suppl, 2002,17(12) : 1-40.
  • 6Gutmann H, Fricker G, Torok M, et al. Evidence for different ABC-transporters in Caeo-2 cells modulating drug uptake [J]. Pharm Res, 1999, 16(3) :402-407.
  • 7Grant CE, Kurz EU, Cole SP, et al. Analysis of the Intron-Exon Organization of the Human Multidrug-Resistance Protein Gene (MRP) and Alternative Splicing of Its mRNA [ J ]. Genomics, 1997,45(2) :368-378.
  • 8Deichmann M, Thome M, Egner U, et al. The chemoresistance gene ABCG2 (MXR/BCRP1/ABCP1) is not expressed in melanomas but in single neuroendocrine carcinomas of the skin [J]. J Cutan Pathol, 2005,32(7):467-473.
  • 9Chua YJ, Zalcberg JR. Progress and challenges in the adjuvant treatment of stage II and III colon cancers [J]. Expert Rev Anticancer Ther, 2008,8(4) :595-604.
  • 10Ahmed FE. Molecular markers that predict response to colon cancer therapy [J]. Expert Rev Mol Diagn, 2005,5(3):353- 375.

共引文献14

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部